Analyst Carter Gould works at BARCLAYS and is focused on the Healthcare sector with 283 price targets and ratings documented since 2016 spanning on 21 stocks. Previously, Carter Gould worked at UBS. Analyst's average stock valuation to be materialised ratio is 63.31% with an average time for price targets to be met of 172.43 days.
Most recent stock forecast was given on MTEM, Molecular Templates, Inc at 11-Nov-2022.
Carter Gould best performing recommendations are on ALLK.
The best stock recommendation documented was for ALLK at 12/21/2021. The price target of $36 was fulfilled within 1 day with a profit of $48.39 (57.34%) receiving and performance score of 573.41.
Average potential price target upside